Market Capitalization (Millions $) |
270 |
Shares
Outstanding (Millions) |
12 |
Employees |
- |
Revenues (TTM) (Millions $) |
11 |
Net Income (TTM) (Millions $) |
-38 |
Cash Flow (TTM) (Millions $) |
21 |
Capital Exp. (TTM) (Millions $) |
1 |
Immunome Inc
Immunome Inc is a biotechnology company that specializes in the discovery and development of novel therapies for infectious diseases and cancer. The company uses its proprietary antibody discovery platform to identify and isolate antibodies from individuals who have developed strong immune responses against specific diseases. These antibodies can then be further developed into therapeutic treatments. Immunome focuses on creating targeted therapies that can be used to prevent or treat a wide range of infectious diseases, including COVID-19, as well as certain types of cancer. The company's goal is to harness the power of the immune system to develop innovative and effective treatments that can improve patient outcomes and address unmet medical needs.
Company Address: 665 Stockton Drive Exton 19341 PA
Company Phone Number: 321-3700 Stock Exchange / Ticker: NASDAQ IMNM
|